TLR7/8 agonist 4 hydroxy-PEG10-acid Catalog No.:M17695-C reduction of eIF2α phosphorylation by

reduction of eIF2α phosphorylation by PERK knockdown enhanced cisplatin-induced p53 activation and apoptosis

but not RIPK1

Smiles: CC1(C)[C@@H]2CC[C@]3(C)[C@H](C(=O)C=C4[C@@H]5C[C@](C)(CC[C@]5(C)CC[C@@]34C)C(O)=O)[C@@]2(C)CC[C@@H]1O[C@@H]1O[C@@H]([C@@H](O)[C@H](O)[C@H]1O)C(O)=O

Formula: C21H21N5O4S

AZ-PFKFB3-67 quarterhydrate is potent and selective metabolic kinase PFKFB3 inhibitor

TLR7/8 agonist 4 hydroxy-PEG10-acid Catalog No.:M17695-C reduction of eIF2α phosphorylation byTLR7 8 agonist 4 hydroxy PEG10 acid (compound 9) is a drug linker conjugate for ADC with potent antitumor activity by using TLR7 8 agonist 4 (HY 139018; a TLR7 8 agonist), linked via the cleavable ADC linker hydroxy PEG10 acid (HY 133307). Product information CAS Number: 2388520 17 8 Molecular Weight: 837. 01 Formula: C41H68N6O12 Chemical Name: 1 (4 {4 amino 2 butyl 1H imidazo[4, 5 c]quinolin 8 yl}piperazin 1 yl) 3, 6, 9, 12, 15, 18, 21, 24, 27, 30